Skip to main content Skip to footer

Press Releases

Bringing Science to Society™

Investors

Investors

  • Overview
  • Press Releases
  • Investor Events
  • Presentations
  • Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Board Committees
  • Stock Information
    • Quote
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
Jan 03, 2022 7:00am EST

Recro to Present at H.C. Wainwright BioConnect 2022 Conference

Dec 02, 2021 7:00am EST

Recro to Present at Stephens Annual Investment Conference

Nov 09, 2021 4:05pm EST

Recro Reports Third Quarter 2021 Financial Results

Nov 02, 2021 4:05pm EDT

Recro to Report Financial Results for Third Quarter 2021 on November 9, 2021

Oct 27, 2021 7:00am EDT

Recro Enters Into Master Commercial Supply and Services Agreement With Otsuka

Oct 20, 2021 7:00am EDT

Recro Awarded Development and Manufacturing Contract by National Institutes of Health (NIH) to Support Novel Nasal Spray Analgesic

Oct 06, 2021 7:00am EDT

Recro Reports Inducement Grants For New Staff

Sep 21, 2021 7:00am EDT

Recro Signs Renewable Energy Agreement With Georgia Power

Sep 08, 2021 7:00am EDT

Recro and BioCorRx Expand Development and Manufacturing Relationship to Support BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder

Aug 17, 2021 7:00am EDT

Recro to Host Webcast to Discuss Acquisition of San Diego-Based IRISYS

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 24
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Copyright ©2023 Societal CDMO. All rights reserved. Manage Cookie Preferences
Follow us